Drug
Azd-6280 clinical trials
Also written AZD6280.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2008 (3)
| Year | Studies |
|---|---|
| 2008 | 3 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses azd-6280 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280CompletedPhase 1AstraZenecaNCT00681746Written as AZD6280
- AZD6280 Multiple Ascending Dose StudyCompletedPhase 1AstraZenecaNCT00681317Written as AZD6280
- Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2)CompletedPhase 1AstraZenecaNCT00824057Written as AZD6280
- A Sedation/Cognition/EEG Study Using AZD6280 and ComparatorCompletedPhase 1AstraZenecaNCT00750802Written as AZD6280
Codes
What other systems call azd-6280 · ClinicalTrials.gg INT006374
- Wikidata Q27274557azd-6280One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27274557 | azd-6280 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.